Follow our progress.

Milestones in our journey to reinvent genetic testing.

View full list

Press Releases

Invitae to present at the Goldman Sachs 38th Annual Global Healthcare Conference

Invitae to present at the Goldman Sachs 38th Annual Global Healthcare Conference

June 01, 2017

Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced that Randy Scott, executive chairman of Invitae, will present at the Goldman Sachs 38th Annual Global Healthcare Conference on Thursday, June 15, 2017 at 8:40 a.m. Pacific at the Terranea Resort in Rancho Palos Verdes, California.

The live, listen-only webcast of the presentation may be accessed by visiting the investors section of the company’s website at ir.invitae.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the company’s website.

About Invitae
Invitae Corporation's (NYSE: NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Invitae's goal is to aggregate most of the world's genetic tests into a single service with higher quality, faster turnaround time, and lower price than many single-gene and panel tests today. The company currently provides a diagnostic service comprising approximately 1,500 genes for a variety of genetic disorders associated with oncology, cardiology, neurology, pediatrics, and other rare disease areas, as well as a clinical whole exome analysis service. Additionally, the company has created a Genome Network to connect patients, clinicians, advocacy organizations, researchers, and therapeutic developers to accelerate the understanding, diagnosis, and treatment of hereditary disease. For more information, visit our website at invitae.com.

Source: Invitae Corporation

Contact:
Kate McNeil
ir@invitae.com
347-204-4226

Share

Return to press releases